Last reviewed · How we verify
Short duration of aspirin and prasugrel
Short duration of aspirin and prasugrel is a Small molecule drug developed by Odense University Hospital. It is currently FDA-approved.
At a glance
| Generic name | Short duration of aspirin and prasugrel |
|---|---|
| Sponsor | Odense University Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Safety and Efficacy of Very Short DAPT in Older Patients Undergoing PCI (PHASE3)
- Comparison of Short Versus 12 Months Prasugrel Plus Aspirin in Patients with Acute Coronary Syndromes Treated with Percutaneous Coronary Intervention and Everolimus-eluting Stents (PHASE4)
- ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-3 Study (PHASE4)
- Reduced Antithrombotic Strategy for High Bleeding Risk Patients With Myocardial Infarction (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Short duration of aspirin and prasugrel CI brief — competitive landscape report
- Short duration of aspirin and prasugrel updates RSS · CI watch RSS
- Odense University Hospital portfolio CI
Frequently asked questions about Short duration of aspirin and prasugrel
What is Short duration of aspirin and prasugrel?
Short duration of aspirin and prasugrel is a Small molecule drug developed by Odense University Hospital.
Who makes Short duration of aspirin and prasugrel?
Short duration of aspirin and prasugrel is developed and marketed by Odense University Hospital (see full Odense University Hospital pipeline at /company/odense-university-hospital).
What development phase is Short duration of aspirin and prasugrel in?
Short duration of aspirin and prasugrel is FDA-approved (marketed).